Combination Treatment with a Novel Polyherbal Formulation and Metformin: A Single Blind Placebo-Controlled Study in Patients with T2DM and Cognitive Impairments
Journal Title: Diabetes Research – Open Journal - Year 2015, Vol 1, Issue 4
Abstract
Background: Older people suffering from Type 2 Diabetes Mellitus (T2DM) are at major risk for age related cognitive dysfunction and dementia, mainly due to vascular complications. Studies have shown that T2DM is also associated with Alzheimer’s Disease (AD) and is responsible for accelerating the pathology through insulin resistance. A polyherbal drug containing Bacopa Monnieri, Hippophae rhamnoides and Dioscorea bulbifera has shown a potent neuroprotective effect in management of cognitive deficits in elderly; and metformin a well-accepted antidiabetic agent responsible for lowering blood glucose in T2DM, can together provide an intriguing potential combination therapy for prevention and amelioration of cognitive impairments in T2DM patients. Objective: The present study is aimed to evaluate the combined effect of a polyherbal drug and metformin on improving cognitive functions in patients suffering from T2DM. Method: Elderly patients with an age range of 60-75 years diagnosed for T2DM were enrolled in the study and randomized into two groups; Group I=T2DM patients given metformin and placebo, Group II=T2DM patients given metformin and polyherbal drug. The subjects received the combination therapy of metformin (500 mg) and placebo or metformin (500 mg) and polyherbal drug (500 mg) twice daily for a period of 24 weeks. Estimation of Mini Mental State Examination (MMSE) score, blood glucose, HbA1c, insulin, lipid profile (total cholesterol, LDL-c, HDL-c, triglycerides), homocysteine, Interleukin-6 (IL-6), TNF-α and C-reactive protein (CRP) were measured at baseline and were repeated at three months and six months. The primary end point was a change from baseline to week 24 in MMSE score. Key secondary end points included change from baseline to week 24 in Digital Symbol Substitution (DSS); subtest of the Wechsler Adult Intelligence Scale-Revised), word recall (digital memory apparatus – Medicaid systems, Chandigarh, India), attention span (Attention Span Apparatus – Medicaid systems, Chandigarh, India), Functional Activity Questionnaire (FAQ) and Hamilton Depression Scale (HDS) score. Further inflammatory markers and level of oxidative stress were analysed using standard biochemical tests. Result: The trial was performed in 120 elderly diabetic patients out of whom 112 patients completed the study for 24 weeks. Statistically significant differences were found between the two groups after intervention on cognitive performance indicated by MMSE, DSS, word recall, attention span, FAQ, HDS, and memory span scores; inflammatory markers such as C-reactive protein (CRP), interleukin-6 (IL-6), Interferon-α (INF-α) and Tumor necrosis factor-α (TNF-α); oxidative stress markers like Superoxide dismutase (SOD), Glutathione peroxidase (GPx), Glutathione (GSH) and Thiobarbituric acid reactive substances (TBARS); and neurodegeneration marker Homocysteine (Hcy). However, no significant variations were indicated between groups in serum insulin and HbA1c levels after intervention of 24 weeks. Conclusion: The results of this study demonstrate the therapeutic potential of the combination therapy of a polyherbal drug and metformin. These results also support longer trials of this combination therapy for patients with mild cognitive impairment and diabetes.
Authors and Affiliations
Ananya Sadhu
Keywords
Related Articles
- EP ID EP550114
- DOI 10.17140/DROJ-1-116
- Views 123
- Downloads 0
Association of Total and Differential White Blood Cell Counts to Development of Type 2 Diabetes in Mexican Americans in Cameron County Hispanic Cohort
Objective: To evaluate the relationship between total and differential White Blood Cells (WBC) counts with time to transition to type 2 diabetes in Mexican Americans using prospective data from the Cameron County Hispani...
Substitution of Chronic Insulin Therapy with Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Co-transporter-2 Inhibitors
Insulin is a very useful and widely used treatment for diabetes. Temporary insulin therapy improves glucose toxicity due to improved β-cell function of the pancreas. Upon achieving glycemic control, insulin treatment cou...
Population-Based Strategy for Preventing Diabetes and its Complications
A recent report from the American College of Physicians (ACP) should cause a paradigm change for the treatment of diabetic patients.1 The main purpose of diabetes therapy is the prevention of complications.2 The endpoi...
An Overview of Diabetes and its Complications
Diabetes mellitus is a metabolic disorder in which the body’s capacity to utilise glucose, fat and protein is disturbed due to impairment in insulin secretion and/or insulin resistance leading to chronic hyperglycaemia....
Unanticipated Difficult Laryngoscopy in a Diabetic Patient Undergoing Coronary Artery Bypass Graft Surgery
Difficult laryngoscopy has been shown to be more frequent in cardiac surgery versus general surgery. In one study, the incidence of difficult laryngoscopy in cardiac surgery was almost double that compared to general sur...